Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Income towards Parent Company (2009 - 2016)

Updated

Analysis

Kazia Therapeutics (KZIA) Income towards Parent Company (2009 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -9.12 Mn
Dec 31, 2015 -5.26 Mn
Sep 10, 2015 -5.28 Mn
Dec 31, 2014 -6.39 Mn
Dec 31, 2013 -2.83 Mn
Aug 30, 2013 -3.86 Mn
Dec 31, 2012 495,633.25
Dec 31, 2011 15.11 Mn
Dec 31, 2010 16.70 Mn
Jun 30, 2010 -13.48 Mn
Dec 31, 2009 -21.62 Mn
API Access

Kazia Therapeutics Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=KZIA&period=max&api_key=YOUR_API_KEY